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Here, we describe a systematic search for synthetic gene interac-
tions in a multicellular organism, the nematode Caenorhabditis
elegans. We established a high-throughput method to determine
synthetic gene interactions by genome-wide RNA interference and
identified genes that are required to protect the germ line against
DNA double-strand breaks. Besides known DNA-repair proteins
such as the C. elegans orthologs of TopBP1, RPA2, and RAD51, eight
genes previously unassociated with a double-strand-break re-
sponse were identified. Knockdown of these genes increased
sensitivity to ionizing radiation and camptothecin and resulted in
increased chromosomal nondisjunction. All genes have human
orthologs that may play a role in human carcinogenesis.
DNA double-strand break  synthetic gene interactions 
Caenorhabditis elegans
The availability of genome-wide gene inactivation approachesin model organisms such as Saccharomyces cerevisae (1, 2)
and Caenorhabditis elegans (3, 4) has contributed immensely to
the understanding of gene function, but a large fraction of genes
remain unclassified. One explanation for the absence of appar-
ent abnormal phenotypes upon gene inactivation is genetic
redundancy, resulting from functional complementation by a
similar gene or a parallel pathway (5), which can be uncovered
by inactivation of two genes simultaneously, resulting in a
so-called synthetic phenotype.
Synthetic genetic analysis has proved to be a powerful method
to build gene-interaction networks in yeast (6–8). The nematode
C. elegans is used widely as a multicellular model organism and
is evolutionarily closer to humans than yeast, which, for example,
lacks the main regulators of apoptosis, such as p53. Synthetic
interactions have been identified successfully in C. elegans by
using mutagenesis (9–11). However, this approach requires
construction of a rescuing transgene and subsequent identifica-
tion of the second-site mutation by means of time-consuming
positional cloning, which hampers a broad applicability.
Currently, C. elegans genes can be inactivated systematically by
feeding animals genetically engineered Escherichia coli clones
that express double-stranded RNA for 86% of the genes encoded
by the C. elegans genome (3, 4, 12). In principle, this powerful
genetic tool allows for (semi-)automated high-throughput anal-
ysis of biological function.
Here, we report the use of high-throughput RNA interference
(RNAi) for systematic identification of synthetic gene interac-
tions. We identified genes that are involved in the cellular
response to DNA double-strand breaks (DSBs); cells respond to
DSBs through the actions of systems that detect the DNA
damage, subsequently triggering various downstream events,
including repair. Such genes are of great clinical importance:
inaccurate repair of DSBs can lead to mutations or to larger-
scale genomic instability (i.e., translocations or aneuploidy) with
accompanying tumorigenic potential. Indeed, many genes in-
volved in repair andor signaling of DSBs are causally implicated
in cancer (13).
Materials and Methods
Strains. We used the following C. elegans strains: wild-type
Bristol N2, NL1832(pk732), and TY1774 yIs2[xol-1::lacZ rol-
6(pRF4)] IV.
Synthetic Lethality Assay. In the pilot experiment, we tested 74
DNA damage-response genes that were used as ‘‘bait’’ by
Boulton et al. (14), which were present in the Ahringer RNAi
library (4). RNAi bacteria from an overnight culture in Luria
broth medium containing 50 gml1 ampicillin were induced
with 0.25 mgml1 isopropylthiogalactoside at 37°C for 4 h and
then seeded on 4-cm nematode growth-medium plates contain-
ing 50 gml1 ampicillin and 200 gml1 isopropylthiogalac-
toside. We placed 30 synchronized L1 larvae on fresh RNAi
plates and transferred 3  3–5 animals to a single RNAi plate
after 3 days of growth at 20°C. These animals were allowed to lay
eggs for 1 day. We removed the parents and counted dead eggs
after 24 h and offspring after 48 h.
RNAi in Liquid 96-Well Culture. We inoculated 96-well-deep blocks
with 500 l of Luria broth medium containing 50 gml1
ampicillin per well, grew the cultures overnight at 37°C, and
induced the bacteria as described above. Worm cultures were
synchronized by bleaching and hatching in M9 at 20°C overnight.
For RNAi cultures in liquid, we put 10–20 L1 larvae in 50 l of
M9 per well of a flat-bottom 96-well tissue-culture plate. M9
buffer consists of M9 buffer with 10 gml1 cholesterol50
gml1 ampicillin12 gml1 tetracycline200 gml1 isopro-
pylthiogalactoside0.1 gml1 fungizone. We added 100 l of
induced bacterial suspension per well and grew the RNAi
cultures at room temperature while shaking at 150–200 rpm. We
scored worm cultures after 5 days for growth. Genome-wide, we
found 929 foods that give a reduction of growth. This set showed
an overlap with 68% (588 of 865) of the foods that have been
reported to give sterility andor 50% lethality (4). Screening
16,757 clones resulted in a total of 32 genes that scored positive
in the synthetic lethality assay (Table 1 and Table 2, which is
published as supporting information on the PNAS web site). The
identity of all positive clones was verified by sequencing. To
exclude an rrf-3-like hypersensitivity to RNAi, we compared the
published RNAi phenotypes of the 32 positive genes in N2 and
rrf-3(pk1426) background and found only 5 of 32 foods to give
a 50% lethality in rrf-3. Given the fact that the set of 32 was
preselected against lethality in N2 and the variance in RNAi
screens, these data indicate that NL1832 does not show an
rrf-3-like hypersensitivity to RNAi.
Radiation-Sensitivity Assay. Synchronized wild-type L1 worms
were grown on RNAi foods in liquid for 2 days at 20°C, as
This paper was submitted directly (Track II) to the PNAS office.
Abbreviations: DSB, double-strand break; RNAi, RNA interference.
*To whom correspondence may be addressed. E-mail: plasterk@niob.knaw.nl and
tijsterman@niob.knaw.nl.
© 2004 by The National Academy of Sciences of the USA
12992–12996  PNAS  August 31, 2004  vol. 101  no. 35 www.pnas.orgcgidoi10.1073pnas.0403131101
described above. L4 animals were subsequently irradiated at 60
Gy, and five or six animals were transferred to a nematode
growth-medium plate containing the corresponding RNAi food.
These animals were allowed to lay eggs for 2 days. We removed
P0 animals, and we counted eggs after 24 h and offspring after
48 h to calculate the percentage of lethality. As a control
experiment, we tested 40 genes from plate 72 of the Ahringer
library (including C27F2.10), and we found one food other than
the positive control giving increased radiation sensitivity.
Camptothecin-Sensitivity Assay. We performed RNAi and deter-
mined the percentage of lethality exactly as was done in the
radiation-sensitivity assay (described above). L4 animals were
exposed to 0.14 mM camptothecin (Sigma) in M9 containing
0.5% DMSO for 2 h. Control animals were treated with 0.5%
DMSO in M9. Pictures were taken 24 h after exposure to
camptothecin. In a control experiment (see above), we found two
additional foods yielding camptothecin sensitivity.
Chromosomal-Instability Assay. We grew 50 yIs2 [xol-1::lacZ
rol-6(pRF4)] L1 larvae in liquid RNAi until they reached late L4
stage. These animals were irradiated at 60 Gy and transferred to
fresh RNAi agar plates. These plates were checked for the
absence of males. We stained for -galactosidase activity with
X-gal 24 h after irradiation, counted the number of blue eggs per
worm, and photographed the animals. Only animals containing
10 eggs were included. We choose the xol-1 assay as an assay
for chromosomal loss after irradiation instead of counting
percentage of males or directly observing chromosomes in
oocytes because it is quantitative, scalable, and usable in com-
bination with dead or dying embryos.
Results
In our experimental setup, we screened for synthetic lethality by
using a C. elegans strain (NL1832) that displays a mutator
phenotype (an increased level of spontaneous mutations) as a
result of DNA transposons jumping freely in its germ-line
lineage (15). The C. elegans genome contains many active DNA
transposons that are normally silenced in the germ line; loss of
this silencing causes increased levels of DSBs as transposons
excise from the genome (15, 16). Most transposon mutators are
defective for RNAi; however, NL1832 is the strongest mutator
strain that is completely RNAi proficient. This strain contains a
mutation in the gene T24C4.1, which has been identified as a
mutator gene by means of RNAi (17). We found a mutation in
a highly conserved amino acid in the peptidase family M16
domain (G51R): a drastic amino acid change that is likely to
affect protein function. How T24C4.1 plays a role in transposon
silencing is unclear. As a consequence of enhanced DSBs in the
mutator background, we hypothesized that inactivation of a gene
essential for DSB repair by RNAi could lead to lethality or a
severely reduced brood size in NL1832 animals but not in a
wild-type background.
To test this hypothesis, we performed RNAi against a broad
spectrum of DNA damage-response genes (74 in total), such as
nucleotide-excision repair, mismatch repair, base-excision re-
pair, nonhomologous end joining, homologous recombination,
and checkpoint pathways (14). Three genes known to be required
specifically for DSB repair were found to show synthetic lethality
Table 1. Genes that show synthetic lethality with the mutator phenotype with ionizing radiation and camptothecin
Category Cosmid no. C. e. NL1832 Irradiation Camptothecin H. s. S. c. Description
DSB response Y43C5A.6 rad-51    RAD51 RAD51 Binds single-stranded DNA during DSB
repair by homologous
recombination.
DSB response M04F3.1 —    RPA2 RFA2 Plays essential role in DNA replication,
nucleotide-excision repair, and
homologous recombination.
DSB response F37D6.1 —    TOPBP1 — DNA topoisomerase II-binding
protein, colocalizes with DNA DSBs,
substrate of ATM kinase.
Protein degradation Y65B4BR.4A —    WWP2 RSP5 E3 ubiquitin ligase, S. pombe
homologue is involved in targeted
degradation of cdc25.
Protein degradation Y41C4a.10 elb-1   — TCEB2 — Ubiquitin-like protein, binds von
Hippel-Lindau tumor-suppressor
complex and thereby inhibits
transcription elongation.
Protein degradation H19N07.2A —   — USP7, HAUSP UBP15 Ubiquitin specific protease, stabilizes
p53 levels.
Protein degradation Y67D8C.5 —   — UREB1, LASU1 TOM1 E3 ubiquitin ligase with a HECT
domain.
Protein degradation C52D10.9 skr-8   — SKP1A* SKP1* Member of the SKP1 family of
proteins, part of E3 ubiquitin ligase
complex.
Other F33H1.3 —   — WBP11, SNP70 — Contains a WW binding domain.
Other K03H1.2 mog-1  —  PRP16, DDX38 PRP16 Protein required for switch from
spermatogenisis to oogenesis.
Other C27F2.10 —    FLJ11305 THP1 Contains a transcription associated
recombination domain. S. c. THP1
shows strong hyperrecombination
phenotype.
C. e., C. elegans; H. s., Homo sapiens; S. c., S. cerevisiae.
*Homolog instead of ortholog. In this case, the reciprocal BLAST did not return the original C. elegans gene as a first hit.






with DNA transposition, namely, rad-51, M04F3.1, and F37D6.1
(see Fig. 4, which is published as supporting information on the
PNAS web site). rad-51 is the C. elegans homolog of mammalian
RAD51, which binds single-stranded DNA during repair of
DSBs by means of homologous recombination (13). M04F3.1 is
the homolog of human RPA2, a subunit of the heterotrimeric
replication protein A. Replication protein A is known to enhance
the single-stranded DNA-binding activity of RAD51 (18).
M04F3.1 is the only subunit of the C. elegans replication protein
A for which RNAi knockdown results in a viable phenotype.
F37D6.1 is the C. elegans homolog of TopBP1, a protein that
interacts with DNA topoisomerase II and colocalizes with
DNA DSBs (19).
We next used RNAi on a high-throughput, genome-wide scale
by culturing animals in liquid 96-well format, with each well
containing an E. coli strain expressing double-stranded RNA
directed against a different C. elegans gene (Fig. 1A). Because
glycerol stocks, bacterial cultures, and worm cultures are in a
96-well format, the number of practical steps was reduced to a
minimum. All liquid handling was done with regular 12-channel
and repeating pipettes. This setup enables one to screen the
RNAi library (4), consisting of E. coli strains producing double-
stranded RNA against 16,757 of the 19,427 predicted individual
C. elegans genes within 5 weeks. To compare the effectiveness of
RNAi via liquid culture with culturing on conventional solid agar
plates, we scored clones that reduced the brood size of wild-type
N2 animals in liquid culture and compared these with published
data for solid culturing (4). This comparison led to an overall
confirmation rate of 68% for clones inducing a strong nonviable
phenotype. Although this result may suggest that the liquid
approach is less efficient, similar levels (75%) of interexperi-
mental f luctuations have been reported in comparing solid-
plate-based genome-wide RNAi screens (12).
In the genome-wide screen for synthetic lethality, assaying the
wild-type N2 control and NL1832 animals side-by-side facili-
tated scoring by visual inspection. We scored RNAi foods as
positive if the brood size of the NL1832 culture was reduced
significantly compared with the wild-type control (Fig. 1B).
Positives were repeated in triplicate, omitting genes whose
knockdown by RNAi is already known to result in sterility or high
embryonic lethality in wild-type animals (3, 4) to avoid effects of
cumulative lethality. Positive clones were subsequently quanti-
fied for synthetic lethality on agar plates (Fig. 4). Screening
16,757 clones resulted in a total of 32 genes showing synthetic
lethality with the mutator phenotype (Tables 1 and 2), including
two of the three genes identified in the pilot screen.
To test which genes are genetically downstream of transposon-
induced DSBs, we generated DSBs in two other ways: by ionizing
radiation and by camptothecin. Although ionizing radiation
induces a broad spectrum of DNA lesions, DSBs are considered
to be the main cytotoxic lesions (20). We found that inactivation
of 10 of the 32 genes synthetic to the mutator phenotype caused
a clear increase in embryonic lethality after irradiation (Fig. 2a
and Table 1). Camptothecin inhibits the release of DNA topo-
isomerase I from DNA, leaving a single-strand break. When a
DNA replication fork collides with this complex, the single-
strand break is converted to a DSB. Because active replication
is required to generate camptothecin-induced DSBs, its main
cytotoxic effects take place during S phase (21). In yeast,
camptothecin induces a strong cell-cycle arrest (22). We found
that camptothecin also induces a cell-cycle arrest in C. elegans
(Fig. 2b). RNAi against the 32 previously identified genes
yielded 6 genes that were sensitive to camptothecin (Fig. 2c and
Fig. 1. RNAi by feeding in 96-well-format liquid cultures. (A) Schematic representation of the liquid RNAi-feeding protocol. The bacterial RNAi library is in a
96-well format, which is used to inoculate bacterial cultures overnight. This bacterial suspension is added to15 L1 larvae in M9 buffer. The worm cultures are
shaken at 20°C for 4–5 days and scored by visual inspection for wells with reduced growth. To facilitate scoring, N2 control and NL1832 are loaded in wells next
to each other. (B) Examples of worm cultures showing synthetic lethality. (Upper) Wild-type worms fed on empty vector (M04F3.1, C27F2.10, and K03H1.2
double-stranded RNA producing clones). (Lower) NL1832 worms.
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Table 1). Knockdown of five of these six genes causes sensitivity
to both ionizing radiation and camptothecin. As a negative
control, 40 randomly picked genes were tested for ionizing
radiation and camptothecin sensitivity, yielding one and two
positives, respectively, demonstrating the specific enrichment of
DNA damage-response genes in our primary screen.
We next investigated chromosomal aberrations resulting from
irradiation in the RNAi knockdowns. Expression of the C.
elegans gene xol-1 reflects the X-chromosome-to-autosome ratio
during early embryogenesis and triggers male (XO) or hermaph-
rodite (XX) development (23). In a male, embryo xol-1 is
expressed, but in hermaphrodite embryos, which constitute
99.8% of the wild-type brood, xol-1 is silent. We used transgenic
animals that carry a LacZ reporter gene driven by the xol-1
promoter (23), as a marker for X-chromosomal nondisjunction.
We expected that loss of an X-chromosome due to an improper
DSB response would activate the xol-1 gene and, thus, show up
as a blue egg upon staining animals for -galactosidase activity.
Indeed, RNAi against 9 of the 10 radiation-sensitive genes
resulted in an increased number of embryos with chromosomal
aberrations upon irradiation (Fig. 3). This experiment demon-
strates that the genes that we have identified in a screen for
synthetic lethality with transposon-induced DNA damage are
required to prevent chromosomal aberrations after exogenously
induced DSBs.
Discussion
The first class of genes, which is introduced in Table 1, consists
of genes known to play a role in the DSB response, namely
rad-51, M04F3.1, and F37D6.1 (described above). Interestingly,
most of the newly identified genes are expected to play a role in
targeted protein degradation. Y65B4BR.4A is a ubiquitin E3
ligase. The Schizosaccharomyces pombe homolog of
Y65B4BR.4A is involved in the targeted degradation of CDC25
(24), which is an important effector in the DNA-damage-
checkpoint response. H19NO7.2a is the C. elegans homolog of
mammalian USP7HAUSP, a ubiquitin-specific protease that
stabilizes p53 levels (25). Aberrations in both p53 and CDC25A
are found in many types of human cancer (26). The three other
members of the protein degradation class are elb-1, Y67D8.5,
and skr-8. elb-1 encodes a ubiquitin-like protein, the S. cerevisiae
homolog of Y67D8.5 is an ubiquitin E3 ligase (27), and skr-8 is
a member of the SKP1-related family. Mammalian Skp1 func-
tions as a core component of the Skp1-Cdc53Cul1-F-box (SCF)
protein E3 ubiquitin ligase complexes, which mediate the deg-
radation of a range of proteins such as cell-cycle regulators and
transcription factors (28). Several DSB response factors are
regulated by ubiquitination, such as RAD51, histones, CDC25A,
and p53 (29). Our data support the hypothesis that DSB-
response pathways are regulated by means of such degradation
(29), perhaps with proteasomal targeting serving as an important
onoff switch; lack of regulation of the DSB response is only
harmful at a threshold amount of DNA damage, which explains
the wild-type phenotypes being observed without DNA damage.
In the genome-wide screen, we identified 32 genes that show
synthetic lethality with the mutator phenotype. Of these genes,
11 genes were confirmed in secondary assays, namely, radiation
Fig. 2. Genes showing synthetic lethality with NL1832 are also sensitive to
DNA breaks induced by radiation and camptothecin. (a) Radiation sensitivity.
L4 worms fed on RNAi foods were irradiated with 60 Gy. The percentage of
lethality was determined by counting the number of dead eggs in the total
brood. All 32 genes that show synthetic lethality with NL1832 were tested.
Only genes with an increased sensitivity to ionizing radiation are shown. Data
represent mean  SD of five to six experiments. (b) Camptothecin induces
cell-cycle arrest in C. elegans. Staged animals treated with 0.14 mM campto-
thecin for 2 h were photographed after a 24-h recovery. Camptothecin-
treated worms show less germ-cell nuclei and the size of remaining nuclei and
their cytoplasm becomes greatly enlarged (arrows). Furthermore, the absence
of mature oocytes is evident in camptothecin-treated worms. (c) Camptoth-
ecin sensitivity. Worms were treated, and the percentage of lethality was
determined as described above. Blue bars indicate lethality in broods from
mock-treated animals, and red bars represent lethality in broods from camp-
tothecin-treated worms.
Fig. 3. Knockdown of genes conferring radiation sensitivity results in in-
creased radiation-induced X-chromosomal nondisjunction. Xol-1::lacZ (yIs33)
worms were fed RNAi foods that have been found to cause radiation sensi-
tivity. (a and b) Worms were irradiated at L4 stage and stained for galactosi-
dase activity after 24 h. As an example, worms fed on empty-vector control (a)
and M04F3.1 food (b) are shown. (c) The number of blue eggs per worm was
counted for all 10 RNAi foods that cause radiation sensitivity. Data represent
mean  SD of three experiments.






sensitivity (10 genes), camptothecin sensitivity (6 genes), and
increased chromosomal nondisjunction after irradiation (9
genes). There are several explanations for the fact that not all
RNAi knockdowns of the genes that we identified in the primary
screen are sensitive to exogenously induced DSBs. First, these
genes do not necessarily function genetically downstream of
transposon-induced DSBs; for example, knockdown of a gene
involved in chromosome organization might result in a higher
accessibility of the DNA to the transposase, resulting in in-
creased lethality in an transposon-activated background. In
addition, DSBs induced by transposition, radiation, and camp-
tothecin have different characteristics, such as cell-cycle phase
and the time window in which they are induced. It is unknown
at which stage during the cell-cycle transposons excise from the
genome; camptothecin induces DSBs during S phase, whereas
radiation is expected to induce breaks at all cell phases, explain-
ing both the smaller subset of camptothecin resistance genes (6
vs. 10 genes) and the large overlap with the radiation resistance
genes (5 of 6 genes). Also, we cannot exclude the possibility that
some of the observed synthetic lethal interactions are due to
synthetic effects with mutations in the mutator background and,
thus, are not related directly to activated transposition in the
germ line.
It is difficult to speculate on the ‘‘success rate’’ of this screen
and how many genes were not identified. Obviously, because
RNAi is a knockdown and not a knockout approach, genes
have been missed. However, using RNAi could also be con-
sidered as an advantage because some of the genes that we
identified are expected to be essential and would have been
overlooked (for example, in reverse genetic approaches). We
also compared our results with a study that used phylogenetic
comparison and two-hybrid interaction data to identify C.
elegans genes that act in response to DNA damage (14), and we
found four genes to be present in both data sets. Apart from
biological differences, the limited overlap also could result
from the relatively mild stress induced by transposon hopping.
Perhaps a broader range of DNA damage-response genes
would result from screening with more severe DNA-damaging
conditions, such as ionizing radiation.
To our knowledge, many of the genes that we identified have
not been found previously in screens for sensitivity to DNA
damage in yeast (or bacteria). In some cases, this absence of
overlap is explained by the lack of a clear S. cerevisiae ortholog.
However, another reason could be that complete loss of the gene
product is incompatible with growth. Indeed, four genes proved
to be essential in yeast, and the absence of such essential genes
in yeast knockout arrays is a recognized drawback (6). Because
RNAi is temporal and, perhaps more important, not completely
penetrant, a higher fraction of genes can be tested in C. elegans.
Reverse genetic approaches in yeast and worms are comple-
mentary, and a future cross-species comparison of synthetic gene
relations will help to identify highly conserved interactions, as
seen for two-hybrid data (30). Furthermore, genome-wide high-
throughput RNAi permits efficient detection of chemical–
genetic interactions, as shown for camptothecin in this study.
We have set up a protocol for screening for synthetic gene
interactions in C. elegans and provided proof of concept by the
identification of 11 genes that protect cells against genomic
instability. The molecular nature of these genes implies that
specific targeting of protein degradation is an important regu-
lator of the DSB response. Further understanding of these genes
may help us to understand mechanisms underlying genomic
instability in cancer and yield putative anticancer drug targets.
In principle, this protocol is applicable in combination with any
viable knockout and allows the simultaneous screening of mul-
tiple strains, thus providing a platform for the construction of
gene-interaction networks.
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